[go: up one dir, main page]

IL98541A0 - Pyrimidinyl compounds,their preparation and pharmaceutical compositions containing them - Google Patents

Pyrimidinyl compounds,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL98541A0
IL98541A0 IL98541A IL9854191A IL98541A0 IL 98541 A0 IL98541 A0 IL 98541A0 IL 98541 A IL98541 A IL 98541A IL 9854191 A IL9854191 A IL 9854191A IL 98541 A0 IL98541 A0 IL 98541A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
pyrimidinyl compounds
pyrimidinyl
Prior art date
Application number
IL98541A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL98541A0 publication Critical patent/IL98541A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL98541A 1990-06-27 1991-06-18 Pyrimidinyl compounds,their preparation and pharmaceutical compositions containing them IL98541A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/544,570 US5098904A (en) 1990-06-27 1990-06-27 Cerebral function enhancing pyrimidinyl derivatives

Publications (1)

Publication Number Publication Date
IL98541A0 true IL98541A0 (en) 1992-07-15

Family

ID=24172727

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98541A IL98541A0 (en) 1990-06-27 1991-06-18 Pyrimidinyl compounds,their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US5098904A (fi)
EP (1) EP0463596A1 (fi)
JP (1) JPH04230279A (fi)
KR (1) KR920000748A (fi)
CN (1) CN1057651A (fi)
AU (1) AU628735B2 (fi)
CA (1) CA2041257A1 (fi)
FI (1) FI912963A (fi)
HU (1) HUT58318A (fi)
IE (1) IE912210A1 (fi)
IL (1) IL98541A0 (fi)
NO (1) NO912448L (fi)
NZ (1) NZ238572A (fi)
PT (1) PT98083A (fi)
ZA (1) ZA914626B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022309A1 (en) * 1992-04-23 1993-11-11 Merrell Dow Pharmaceuticals Inc. 4-imidomethyl-1-[2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
CA2145640C (en) * 1992-09-28 2001-01-30 Banavara L. Mylari Substituted pyrimidines for control of diabetic complications
US5338738A (en) * 1993-04-19 1994-08-16 Bristol-Myers Squibb Company Cerebral function enhancers: acyclic amide derivatives of pyrimidinylpiperidines
US5401744A (en) * 1993-10-04 1995-03-28 Bristol-Myers Squibb Company Useful hemi-hydrate form of a cerebral function enhancing agent
US5601091A (en) * 1995-08-01 1997-02-11 Sonamed Corporation Audiometric apparatus and association screening method
WO2004007444A2 (en) 2002-07-11 2004-01-22 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
US11619880B2 (en) * 2019-05-17 2023-04-04 The Regents Of The University Of Colorado Holographic photopolymer compositions and composites

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
US3558777A (en) * 1968-06-21 1971-01-26 Mead Johnson & Co Pharmacologic processes and compositions containing azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
IL57569A0 (en) * 1978-06-20 1979-10-31 Synthelabo Phenylpiperazine derivative,their preparation and pharmaceutical compositions containing them
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4826843A (en) * 1985-07-08 1989-05-02 Bristol-Myers Cerebral function enhancing diazinylpiperidine derivatives
NZ216720A (en) * 1985-07-08 1990-09-26 Bristol Myers Co Diazinylpiperidine derivatives and pharmaceutical compositions
US4963678A (en) * 1989-10-27 1990-10-16 Bristol-Myers Squibb Co. Process for large-scale production of BMY 21502

Also Published As

Publication number Publication date
HU912123D0 (en) 1991-12-30
HUT58318A (en) 1992-02-28
CA2041257A1 (en) 1992-01-28
FI912963A (fi) 1991-12-28
US5098904A (en) 1992-03-24
FI912963A0 (fi) 1991-06-18
NZ238572A (en) 1993-07-27
EP0463596A1 (en) 1992-01-02
PT98083A (pt) 1992-04-30
IE912210A1 (en) 1992-01-01
NO912448D0 (no) 1991-06-24
AU7627591A (en) 1992-01-02
KR920000748A (ko) 1992-01-29
AU628735B2 (en) 1992-09-17
ZA914626B (en) 1993-02-24
CN1057651A (zh) 1992-01-08
NO912448L (no) 1991-12-30
JPH04230279A (ja) 1992-08-19

Similar Documents

Publication Publication Date Title
IL99225A0 (en) 3-amidopyrazole derivatives,their preparation and pharmaceutical compositions containing them
IL111627A0 (en) Substituted phenylpyrimidine compounds, their preparation and pharmaceutical compositions containing them
IL102638A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL103053A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL100262A0 (en) Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them
IL101864A0 (en) Thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL101763A0 (en) Dialkylenepiperidino compounds and their enantiomers,their preparation and pharmaceutical compositions containing them
IL98176A0 (en) Bicyclic 1-aza-cycloalkanes,their preparation and pharmaceutical compositions containing them
IL101380A0 (en) Bis-naphthalimides,their preparation and pharmaceutical compositions containing them
IL100229A0 (en) N,o-sulphated heparosans,their preparation and pharmaceutical compositions containing them
IL97050A0 (en) 4-isoxazolecarboxamide derivatives,pharmaceutical compositions containing them and their preparation
IL98499A0 (en) Aminobenzodiazepines,their preparation and pharmaceutical compositions containing them
IL98756A0 (en) Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation
IL98542A0 (en) Benzoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL100061A0 (en) Tricyclic compounds,their preparation and pharmaceutical compositions containing them
IL100364A0 (en) Benzodiazepinones,their preparation and pharmaceutical compositions containing them
IL103160A0 (en) Quinoxaline compounds,their preparation and pharmaceutical compositions containing them
IL104099A0 (en) Imidazoquinazoline compounds,their preparation and pharmaceutical compositions containing them
IL102500A0 (en) 3-deoxy-mannosamine derivatives,their preparation and pharmaceutical compositions containing them
IL104042A0 (en) Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them
IL89376A0 (en) Substituted pyrimidines,their preparation and pharmaceutical compositions containing them
IL99637A0 (en) 5h-benzodiazepine derivative,its preparation and pharmaceutical compositions containing it
IL99561A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL98541A0 (en) Pyrimidinyl compounds,their preparation and pharmaceutical compositions containing them
IL105774A0 (en) Thienothiazine derivatives,their preparation and pharmaceutical compositions containing them